Agilent ZORBAX 300SB Series Effect of Bonded Phase Type on Peptide Separation

Significant differences in selectivity can be achieved by changing the ZORBAX StableBond phase. Note selectivity and resolution differences for peptides S1 and S2. Peptides S1-S5 are decapeptides that differ in amino acids at two locations, causing only slight differences in hydrophobicity.


Agilent ZORBAX 300SB Series Effect of Bonded Phase Type on Peptide Separation - cover page
Brand
Agilent
Category
Other
Document type
Product Leaflet
Language
English
Pages
2
File format
PDF
File size
2.6 MB
Published
03 July, 2012
Updated
28 September, 2023
MD5 checksum
41A04DA962C6F0D02D38D0EEF8FD85A9

About this manual

This application note demonstrates significant differences in selectivity and resolution for peptides S1 and S2 when using different ZORBAX StableBond phases (C18, C8, and CN). The study utilizes decapeptides (S1-S5) that differ in amino acids at two locations, resulting in only slight differences in hydrophobicity.

What's inside

  • Effect of Bonded-Phase Type
  • Peptide Separation
  • ZORBAX StableBond Phase
  • Selectivity Differences
  • Resolution Differences
  • Peptides S1-S5
  • Mobile Phase Conditions

Specifications

Column Dimensions4.6 x 150 mm
Column Part Numbers883995-902, 883995-906, 883995-905
Mobile Phase A0.1% TFA in H2O
Mobile Phase B0.085% TFA in ACN
Flow Rate1 mL/min
Detection Wavelength210 nm
Gradient Program0-30% B in 30 min

Frequently asked questions

What is the effect of changing the bonded phase on peptide separation?

Significant differences in selectivity can be achieved by changing the ZORBAX StableBond phase.

What are the part numbers for the ZORBAX columns tested?

The part numbers are 883995-902, 883995-906, and 883995-905.

Download PDF (2.6 MB)

More Agilent Manuals


View all Agilent manuals →